MedTrace Logo

The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children

NCT04524897 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-10-27

No results posted yet for this study

Summary

To evaluate the efficacy of Intra-lesional triamcinolone injection in the management of refractory benign esophageal Stricture in children.

Conditions

  • Esophageal Stricture

Interventions

DRUG

Triamcinolone Injection in treatment of refractory benign Esophageal Stricture in children

Triamcinolone Injection in treatment of refractory benign Esophageal Stricture with endoscopic dilatation

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nagla Abou Faddan, Professor · Assiut University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-10-31
Completion
2022-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04524897 on ClinicalTrials.gov